A CSIRO assessment of whole-of-life greenhouse gas emissions associated with the Queensland coal seam gas (CSG) to liquefied natural gas industry (LNG) has identified major greenhouse gas reduction opportunities for electricity generation. The report into gals and electricity production from the Suart Basin found that switching from black coal to Suart CSG for fuel offered…
By Stuart Corner of IotAustralia Australian IoT platform developer Reekoh has added a number of data integration tools that it says will deliver considerable benefits to its enterprise customers. They are Reekoh Bionic automation tools and Outpost for the IoT Edge. The automation tools include IoT device simulators for hardware-less IoT solution development, and a…
Fast-growing infant formula exporter Bubs Australia (ASX: BUB) has recorded greater sales in the final quarter of the year than it did in the whole of 2018. The producer of formula, organic baby food, and goat dairy products announced sales of $18.46 million in the quarter and $51.3 million for the full year. Bubs CEO…
There is no shortage of Aussie manufacturers applying great ideas. However, I would argue they could do a better job of putting their cleverness forward.
Brent Balinski spoke to CSIRO ON’s David Burt about the challenges involved in commercialising scientific achievements.
Comment by Peter Roberts Everyone seems to want to buy Australia’s iconic manufacturers – except Australians it seems. Despite a multi-trillion dollar superannuation nest egg built up by working Australians, why is it so often only foreign interests that can see value in our manufacturers? Just this past week Arnott’s biscuits, part of Campbell Soup…
Nerve technology developer Orthocell (ASX:OCC) has reported a study validating ‘high quality nerve repair’ from its CelGro treatment. The pre-clinical study indicated CelGro facilitated the regeneration of severed peripheral nerves, returning them to normal nerve structure. This reinforces earlier human trials that CelGro restored nerve sensation, reducing the need for sutures. Orthocell managing director, Paul…
Sales by obstructive sleep apnea treatment pioneer ResMed (ASX: RMD) powered ahead 13 per cent in the final quarter of 2018-19, driven by the release of new products. The Sydney company announced revenue up 13 per cent for the final quarter ended June 30 to $1.02 billion, bringing full year revenue to $3.8 billion. Net…
Strong growth in non-alcoholic grape juice products is helping a South Australian winery increase its presence in Asia.
Space Syatems and weapons manufacturer Electro Optic Systems (ASX: EOS) is in the middle of an international political storm with photographs emerging which put into question its arms exports to the Middle East. EOS, which makes weapons systems that can be remotely operated from inside the protection of an armoured car, has a $450 million…
